Shelter Ins Retirement Plan Abb Vie Inc. Transaction History

Shelter Ins Retirement Plan

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $8.91 Million - $10.4 Million	57,585 New	57,585 $9.88 Million
Q3 2019 Nov 21, 2019	SELL	$62.98 - $75.72 $3.94 Million - $4.74 Million	-62,600 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $365,895 - $451,247	-4,700 Reduced 6.98%	62,600 $5.77 Million
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $754,152 - $892,332	-8,400 Reduced 11.1%	67,300 $6.24 Million
Q3 2017 Nov 03, 2017	SELL	$69.85 - $89.22 $279,400 - $356,880	-4,000 Reduced 5.02%	75,700 $6.73 Million
Q2 2017 Aug 08, 2017	BUY	N/A	79,700	79,700 $5.78 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Shelter Ins Retirement Plan, based on Form 13F filings with the SEC.

Stay updated on Shelter Ins Retirement Plan with notifications on news.